Age at death
|
0.985
|
0.98–0.989
|
< 0.0001
|
Sex
|
Male vs female
|
0.95
|
0.87–1.04
|
0.2533
|
Survival in months
|
1.01
|
1.006–1.02
|
< 0.0001
|
Living in a nursing home
|
0.25
|
0.21–0.30
|
< 0.0001
|
Care level (reference = no care level)
|
1
|
0.47
|
0.42–0.53
|
< 0.0001
|
2
|
0.26
|
0.24–0.29
|
< 0.0001
|
3
|
0.16
|
0.14–0.19
|
< 0.0001
|
Healthcare utilisation
|
Number of hospital days d
|
1.04
|
1.036–1.05
|
< 0.0001
|
Palliative Care
|
Inpatient palliative care
|
1.85
|
1.66–2.08
|
< 0.0001
|
Outpatient palliative care
|
0.25
|
0.20–0.32
|
< 0.0001
|
Chemotherapy in last 30 days of life
|
1.61
|
1.46–1.77
|
< 0.0001
|
Charlson Comorbidities Groups
|
Congestive Heart Failure
|
1.21
|
1.11–1.33
|
< 0.0001
|
Renal Disease
|
1.19
|
1.08–1.32
|
0.0006
|
Body regions with Metastases
|
Cerebral metastases
|
0.86
|
0.77–0.96
|
0.0050
|